Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilmar Ebersbach

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biotechnology Journal|November 10, 2012
Antigen generation and display in therapeutic antibody drug discovery -- a neglected but critical playerHilmar Ebersbach, Sabine Geisse
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2012
Antigen presentation for the generation of binding moleculesHilmar Ebersbach, Gabriele Proetzel, Chonghui Zhang
Journal of Molecular Biology|July 14, 2007
Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet proteinHilmar Ebersbach, Erik Fiedler, Tanja Scheuermann, et al.
Cancers|August 29, 2024
IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor ActivityAnahita Rafiei, Marco Gualandi, Chia-Lung Yang, et al.
Oncotarget|October 30, 2016
Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophagesTatiana Smirnova, Laura Bonapace, Gwen MacDonald, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2020
Targeting interleukin-4 to the arthritic jointValerie Spieler, Marie-Gabrielle Ludwig, Janet Dawson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation StrategiesLawrence L'Italien, Olivia Orozco, Tinya Abrams, et al.
Journal of Inflammation (London, England)|June 25, 2026
Administration of human macrophage colony-stimulating factor-mFc fusion protein increases macrophage phagocytic capacity and stimulates liver regeneration in micePhilip J Starkey Lewis, Jennifer A Cartwright, Lara Campana, et al.
Disease Models & Mechanisms|February 16, 2022
Therapeutic potential of macrophage colony-stimulating factor in chronic liver diseaseSahar Keshvari, Berit Genz, Ngari Teakle, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 20, 2023
Reversible expansion of tissue macrophages in response to macrophage colony-stimulating factor (CSF1) transforms systemic lipid and carbohydrate metabolismSahar Keshvari, Jesse J R Masson, Michelle Ferrari-Cestari, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biotechnology Journal|November 10, 2012
Antigen generation and display in therapeutic antibody drug discovery -- a neglected but critical playerHilmar Ebersbach, Sabine Geisse
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2012
Antigen presentation for the generation of binding moleculesHilmar Ebersbach, Gabriele Proetzel, Chonghui Zhang
Journal of Molecular Biology|July 14, 2007
Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet proteinHilmar Ebersbach, Erik Fiedler, Tanja Scheuermann, et al.
Cancers|August 29, 2024
IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor ActivityAnahita Rafiei, Marco Gualandi, Chia-Lung Yang, et al.
Oncotarget|October 30, 2016
Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophagesTatiana Smirnova, Laura Bonapace, Gwen MacDonald, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2020
Targeting interleukin-4 to the arthritic jointValerie Spieler, Marie-Gabrielle Ludwig, Janet Dawson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation StrategiesLawrence L'Italien, Olivia Orozco, Tinya Abrams, et al.
Journal of Inflammation (London, England)|June 25, 2026
Administration of human macrophage colony-stimulating factor-mFc fusion protein increases macrophage phagocytic capacity and stimulates liver regeneration in micePhilip J Starkey Lewis, Jennifer A Cartwright, Lara Campana, et al.
Disease Models & Mechanisms|February 16, 2022
Therapeutic potential of macrophage colony-stimulating factor in chronic liver diseaseSahar Keshvari, Berit Genz, Ngari Teakle, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 20, 2023
Reversible expansion of tissue macrophages in response to macrophage colony-stimulating factor (CSF1) transforms systemic lipid and carbohydrate metabolismSahar Keshvari, Jesse J R Masson, Michelle Ferrari-Cestari, et al.
Pageof 2